PharmaCyte Biotech Inc. (PMCB): Price and Financial Metrics
PMCB Price/Volume Stats
| Current price | $1.69 | 52-week high | $2.58 |
| Prev. close | $1.62 | 52-week low | $1.39 |
| Day low | $1.63 | Volume | 16,200 |
| Day high | $1.75 | Avg. volume | 18,409 |
| 50-day MA | $1.67 | Dividend yield | N/A |
| 200-day MA | $1.89 | Market Cap | 11.74M |
PMCB Stock Price Chart Interactive Chart >
PharmaCyte Biotech Inc. (PMCB) Company Bio
PharmaCyte Biotech, Inc. (PharmaCyte) is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.” This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed.
PMCB Price Returns
| 1-mo | 3.05% |
| 3-mo | -6.11% |
| 6-mo | -16.34% |
| 1-year | -22.48% |
| 3-year | -17.56% |
| 5-year | -97.92% |
| YTD | 7.64% |
| 2024 | -27.31% |
| 2023 | -26.28% |
| 2022 | 17.20% |
| 2021 | -75.12% |
| 2020 | -83.46% |
Loading social stream, please wait...